$DDS Cashflow Statement | Understand Stock

$DDS

$656.60 -$9.00 (1.35%) Close

$DDS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 31, 2026	FY2024 12 months to Feb 1, 2025	FY2023 12 months to Feb 3, 2024	FY2022 12 months to Jan 28, 2023	FY2021 12 months to Jan 29, 2022
Operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and other deferred cost
Depreciation and amortization of property and other deferred costs
Deferred income taxes
Gain on disposal of assets
Proceeds from insurance
Gain from insurance proceeds
Loss on early extinguishment of debt
Accrued interest on short-term investments
Asset impairment and store closing charges

Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable
(Increase) decrease in merchandise inventories
Decrease (increase) in other current assets
Decrease (increase) in other assets
(Decrease) increase in trade accounts payable and accrued expenses and other liabilities
(Decrease) increase in income taxes payable
Net cash provided by operating activities
Investing activities:
Purchase of property and equipment and capitalized software
Proceeds from disposal of assets
Proceeds from insurance
Purchase of short-term investments
Proceeds from maturities of short-term investments
Distribution from joint venture
Investments related to joint ventures
Net cash provided by (used in) investing activities

Financing activities:
Principal payments on long-term debt and finance lease liabilities
Principal payments on long-term debt
Cash dividends paid
Purchase of treasury stock
Issuance cost of line of credit
Net cash used in financing activities

Increase (decrease) in cash and cash equivalents
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents, end of period
Non-cash transactions of investing and financing activities:
Accrued capital expenditures
Stock awards
Accrued purchases of treasury stock
Accrued purchases of treasury stock and excise taxes
Lease assets obtained in exchange for new operating lease liabilities

Comments